New

Lucid Genomics

The AI engine Fit Assessment

Beta

The company will attend Deep Tech Momentum 2026

Blurb

Lucid Genomics is an AI-powered platform that focuses on diagnostics and biomarker detection.

HQ Location

Berlin (Germany)

Founded

2024

Employees

1 - 10

Total funding raised

$1.74M

Funding Status

Pre-Seed, $1.44M, September 2, 2024

At Lucid Genomics, we are pioneering the future of genomic insights by harnessing the power of advanced artificial intelligence. Our mission is to decode the full potential of the human genome, extracting 100% of DNA data from whole genomes with unprecedented precision and accuracy.



By bridging cutting-edge AI technology with genomic science developed at the Max Planck Institute for Molecular Genetics and Charité – Universitätsmedizin Berlin, we empower researchers, clinicians, and innovators with the tools to unlock new discoveries, accelerate personalized medicine, and shape a healthier future.



Our AI powered Lucid platform

+ covers 100% of the genome screened

+ unlocks large scale cohort analysis

+ reduces false-positive mutations by 87%

+ detects SVs, SNVs and TRs

+ integrates multi-layer omnics



Follow us to stay informed about the latest insights into our pipeline.